Verona Pharma plc Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Verona Pharma plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2025.
Verona Pharma plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $34.8M, a 123% increase year-over-year.
Verona Pharma plc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $93.7M, a 218% increase year-over-year.
Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2024 was $41.2M, a 117% increase from 2023.
Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2023 was $19M, a 34.6% increase from 2022.
Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2022 was $14.1M, unchanged from 2021.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2025	$93.7M	$34.8M	+$19.2M	+123%	Apr 1, 2025	Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$74.5M	$37.5M	+$33.2M	+780%	Jan 1, 2025	Mar 31, 2025	10-Q	2025-04-29
Q4 2024	$41.2M	$13.7M	+$9.17M	+201%	Oct 1, 2024	Dec 31, 2024	10-K	2025-02-27
Q3 2024	$32.1M	$7.65M	+$2.58M	+50.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-04
Q2 2024	$29.5M	$15.6M	+$10.5M	+207%	Apr 1, 2024	Jun 30, 2024	10-Q	2025-08-06
Q1 2024	$19M	$4.26M	-$32K	-0.75%	Jan 1, 2024	Mar 31, 2024	10-Q	2025-04-29
Q4 2023	$19M	$4.57M	+$65K	+1.44%	Oct 1, 2023	Dec 31, 2023	10-K	2025-02-27
Q3 2023	$18.9M	$5.08M	+$2.26M	+80.4%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-04
Q2 2023	$16.7M	$5.07M	+$2.02M	+66.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$14.7M	$4.29M	+$542K	+14.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$14.1M	$4.5M	+$11.6M		Oct 1, 2022	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$2.5M	$2.82M	-$2.12M	-43%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$4.62M	$3.05M	-$4.4M	-59%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$9.02M	$3.75M	-$5.1M	-57.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$14.1M	-$7.12M	-$20M	-155%	Oct 1, 2021	Dec 31, 2021	10-K	2025-02-27
Q3 2021	$34.1M	$4.94M	-$1.55M	-23.9%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	$35.7M	$7.45M	+$6.5M	+684%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$29.2M	$8.85M	+$6.98M	+374%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$22.2M	$12.9M			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-03
Q3 2020		$6.49M			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020		$950K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020		$1.87M			Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.